Sai Life Sciences Limited
- Minimum Investment₹14,094
- Price Range₹522 - ₹549
- Issue Size₹3,042.62 Cr
- Lot Size27 shares
Proceeds of this IPO to be used for
Repayment/prepayment, in full or part, of all or certain outstanding borrowings availed by the company
General corporate purposes
Strengths & Weaknesses of Sai Life Sciences Limited
Among the largest integrated CRDMOs
The company is one of the largest integrated CRDMOs among listed Indian peers in terms of revenue from operations for FY24, serving as a one-stop platform for discovery, development, and manufacturing. (Source: F&S Report)
Diverse mix
The company provides end-to-end development and manufacturing services covering the full value chain for intermediates and APIs
Integrated discovery capabilities
The company's discovery business grew at a CAGR of approximately 34.77% from FY22 to FY24. It added 230 new customers from FY19 to FY24 and served more than 200 customers in each of the financial years 2022, 2023 and 2024
Requires high standards
The company's customers regularly audit and inspect its facilities, processes, and practices to ensure that the services meet their standards in the process. The company may not be able to continue to serve its customers if it fails to meet their standards in audits
Animal testing
The company conducts animal testing, which can result in adverse publicity liability and other issues, including potential disruption to its facilities as a result of protests against animal testing
Intellectual property rights
If the company inadvertently infringes on the patents or intellectual property rights of others, it may be subjected to legal action and its business and reputation may be adversely affected
Financials
Earnings Per Share
No Data
Balance Sheet
Particulars (In Cr) | Y/Y Change | |
---|---|---|
Total Current Assets | -- | |
Total Non-Current Assets | -- | |
Fixed assets | -- | |
Total assets | -- | |
Total Current Liabilities | -- | |
Total Non-Current Liabilities | -- | |
Total Capital Plus Liabilities | -- | |
Total Shareholder Funds | -- | |
Total Debt to Equity | -- |
Cash Flow
Particulars (In Cr) | Y/Y Change | |
---|---|---|
Cash from Operating Activity | -- | |
Cash from Financing Activities | -- | |
Cash from Investing Activities | -- | |
Net Cash Flow | -- |
About Sai Life Sciences Limited
- PromoterKanumuri Ranga Raju
- PromoterKrishnam Raju Kanumuri
- PromoterKanumuri Mytreyi
- PromoterSai Quest Syn Private Limited
- PromoterMarigold Partners
- PromoterSunflower Partners